Xwell Inc Stock Today
| XWEL Stock | USD 1.37 0.08 5.52% |
Performance0 of 100
| Odds Of DistressOver 85
|
XWELL is selling for 1.37 as of the 29th of November 2024. This is a 5.52% down since the beginning of the trading day. The stock's lowest day price was 1.34. XWELL has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for XWELL Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of January 2018 | Category Healthcare | Classification Health Care |
XWELL Inc., a health and wellness services company, provides spa services at airports. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. Xwell operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. The company has 5.26 M outstanding shares of which 71.54 K shares are at this time shorted by private and institutional investors with about 6.97 trading days to cover. More on XWELL Inc
Moving against XWELL Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
XWELL Stock Highlights
| CEO President | Scott Milford | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Personal Services (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Personal Services, Health Care, Biotechnology, Personal Services, Consumer Cyclical (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
XWELL can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand XWELL's financial leverage. It provides some insight into what part of XWELL's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
XWELL Inc (XWEL) is traded on NASDAQ Exchange in USA. It is located in 254 West 31st Street, New York, NY, United States, 10001 and employs 266 people. XWELL is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.2 M. XWELL Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 5.26 M outstanding shares of which 71.54 K shares are at this time shorted by private and institutional investors with about 6.97 trading days to cover.
XWELL Inc currently holds about 71.11 M in cash with (16.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75.
Check XWELL Probability Of Bankruptcy
Ownership AllocationXWELL Inc maintains 9.64 (%) of its outstanding shares held by insiders and 17.55 (%) owned by institutional investors.
Check XWELL Ownership Details
XWELL Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Activest Wealth Management | 2024-06-30 | 50.0 | |
| Bank Of America Corp | 2024-06-30 | 46.0 | |
| Winch Advisory Services, Llc | 2024-09-30 | 25.0 | |
| Fmr Inc | 2024-09-30 | 3.0 | |
| Wells Fargo & Co | 2024-06-30 | 0.0 | |
| Citigroup Inc | 2024-06-30 | 0.0 | |
| Citadel Advisors Llc | 2024-06-30 | 0.0 | |
| Efficient Wealth Management Llc | 2024-06-30 | 0.0 | |
| Old Point Trust & Financial Services N A | 2024-06-30 | 0.0 | |
| Blackrock Inc | 2024-06-30 | 82.7 K | |
| Vanguard Group Inc | 2024-09-30 | 77.1 K |
XWELL Historical Income Statement
XWELL Stock Against Markets
XWELL Corporate Management
| Cara Soffer | Senior Counsel | Profile | |
| David Kohel | Chief Officer | Profile | |
| Suzanne Scrabis | Chief Officer | Profile | |
| Omar Haynes | Interim Officer | Profile | |
| Pablo Henderson | Chief Officer | Profile |
Already Invested in XWELL Inc?
The danger of trading XWELL Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of XWELL is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than XWELL. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile XWELL Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether XWELL Inc is a strong investment it is important to analyze XWELL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact XWELL's future performance. For an informed investment choice regarding XWELL Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XWELL Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XWELL. If investors know XWELL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XWELL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.29) | Revenue Per Share 7.862 | Quarterly Revenue Growth 0.135 | Return On Assets (0.16) | Return On Equity (0.76) |
The market value of XWELL Inc is measured differently than its book value, which is the value of XWELL that is recorded on the company's balance sheet. Investors also form their own opinion of XWELL's value that differs from its market value or its book value, called intrinsic value, which is XWELL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XWELL's market value can be influenced by many factors that don't directly affect XWELL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XWELL's value and its price as these two are different measures arrived at by different means. Investors typically determine if XWELL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XWELL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.